Macronutrient Distribution in Cancer Patients

Primary Recommendations

The European Society for Clinical Nutrition and Metabolism (ESPEN) guidelines recommend increasing the ratio of energy from fat to energy from carbohydrates in weight-losing cancer patients with insulin resistance 1, 2
The American Cancer Society recommends focusing on nutrient-dense, high-fiber carbohydrate sources, such as whole grains, vegetables, legumes, and fruits, and avoiding highly refined carbohydrates and added sugars 4
The ESPEN guidelines suggest allocating protein at 1.0-1.5 g/kg/day, which equals 4-6 kcal/kg/day, and distributing remaining calories based on clinical status 1, 2

Approximately 50-65% of non-protein calories should come from carbohydrates, according to the Praxis Medical Insights guidelines 3
Approximately 30-50% of non-protein calories should come from fats, with an emphasis on monounsaturated fats and omega-3 fatty acids 3, 4
The glucose:fat ratio has shifted from the historical 50:50 toward 60:40 or even 70:30 (favoring carbohydrates) in standard parenteral nutrition, though this is primarily to avoid hyperlipidemia and fatty liver complications 5

Calculate total energy needs at 25-30 kcal/kg/day, according to the Clinical Nutrition guidelines 1, 2, 6
Allocate protein and distribute remaining calories based on clinical status, with a higher fat ratio for weight-losing patients with insulin resistance 1, 2
Ensure simultaneous administration of all macronutrients over 24 hours when using parenteral nutrition, as optimal nitrogen sparing occurs with simultaneous administration 3, 5

Choose whole grains, vegetables, legumes, and fruits over refined carbohydrates and added sugars, as carbohydrate quality matters 4
Emphasize sources of monounsaturated fats and omega-3 fatty acids while limiting saturated fats, as fat quality matters 4
Select lean protein sources low in saturated fat, such as fish, poultry, eggs, low-fat dairy, and legumes 4

Avoid overfeeding, as providing excessive calories can lead to hyperglycemia, hypertriglyceridemia, and metabolic complications without improving outcomes 6, 7
Monitor triglyceride levels and reduce fat content if levels exceed 5 mmol/dL, as most experts recommend avoiding high triglyceride levels 5